21 March 2019
Trackwise Designs Plc
("Trackwise" or the "Company")
Notice of Results
Trackwise, a leading provider of specialist products using printed circuit technology, will announce its results for the year ending 31 December 2018 on Thursday 11 April 2019.
An analyst meeting will take place at 9.30am on the day at the offices of Arden Partners, 125 Old Broad Street, London, EC2N 1AR. Analysts interested in attending the presentation should please contact [email protected]
For further information contact:
Philip Johnston (CEO) / Mark Hodgkins (CFO)
+44 016 8429 9930
Arden Partners plc (Nominated Adviser and Broker)
Ciaran Walsh / Steve Douglas / Daniel Gee-Summons
+44 020 7614 5900
IFC Advisory Limited (Financial PR & IR)
Tim Metcalfe / Miles Nolan / Zach Cohen
+44 020 3934 6600
Notes to editors
Trackwise is an established business that manufactures specialist products using printed circuit technology. The Company consists of two divisions Radio Frequency ("RF") and Improved Harness Technology ("IHT").
The RF business unit manufactures specialist printed circuits which are primarily used in the antenna infrastructure to support the 3G/4G mobile phone networks. However, the technology has a number of other applications which render the RF business a stable revenue generator.
The IHT division utilises the Company's unique proprietary technology, a patented process that Trackwise has developed to manufacture unlimited length multilayer flexible printed circuits. The Directors believe that the technology has many applications but believe one of its primary uses could be to replace traditional wire harness used in a variety of industries.
Trackwise Designs plc was admitted to trading on AIM on 31 July 2018 with the ticker TWD.
For additional information please visit: www.trackwise.co.uk
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.